Compare OMER & GO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OMER | GO |
|---|---|---|
| Founded | 1994 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 894.8M | 941.1M |
| IPO Year | 2009 | 2019 |
| Metric | OMER | GO |
|---|---|---|
| Price | $11.85 | $9.56 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 11 |
| Target Price | ★ $32.50 | $15.27 |
| AVG Volume (30 Days) | ★ 2.4M | 2.4M |
| Earning Date | 11-13-2025 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $4,571,346,000.00 |
| Revenue This Year | N/A | $10.67 |
| Revenue Next Year | N/A | $5.13 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.22 |
| 52 Week Low | $2.95 | $8.96 |
| 52 Week High | $17.65 | $19.41 |
| Indicator | OMER | GO |
|---|---|---|
| Relative Strength Index (RSI) | 46.02 | 45.35 |
| Support Level | $11.44 | $9.06 |
| Resistance Level | $12.18 | $9.67 |
| Average True Range (ATR) | 0.64 | 0.41 |
| MACD | -0.18 | 0.04 |
| Stochastic Oscillator | 13.72 | 51.48 |
Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The drug candidate in the pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.
Grocery Outlet Holding Corp is a grocery store operator in the United States. It is a retailer of quality, name-brand consumables and fresh products sold through a network of independently operated stores. The stores are run by Entrepreneurial independent operators which create a neighborhood feel through personalized customer service and a localized product offering.